Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Post-COVID-19 hair loss is likely due to stress and inflammation.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

Many COVID-19 survivors still face health issues months later, so ongoing medical support is important.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Complete COVID-19 vaccination reduces the risk of long COVID.

The pandemic increased interest in aesthetic treatments due to more online meetings.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.

The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Post-COVID-19 patients are at risk for hair loss.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.